Research on palliative care for blood cancers has surged in recent years, yet a new large-scale mapping study reveals ...
The analysis saw minimal evidence of increased relapse among patients with hematologic cancers and minimal residual disease vs those without. Unrelated umbilical cord blood transplantation (UCBT) ...
Background: The US Department of Veterans Affairs (VA) National Oncology Program (NOP) has established a standard for veteran-focused cancer care across the Veterans Health Administration. This ...
Presenters at the 2026 National ICE-T Conference in Orlando, Florida, discuss the efficacy and safety of novel agents across hematologic disease states. At the 2026 National Immune Cell Effector ...
At the recent American Society of Hematology annual meeting, the 12th annual Friday Scientific Workshop on Hematology and Aging brought together leaders in the field to examine how aging intersects ...
Hematologic malignancy patients face high COVID-19 risk, with 23.5% experiencing severe illness despite vaccination. Mortality rate was 22.4%, influenced by age, active disease, and ICU admission.
Ana Lacerda, MD, MSc, of the Portuguese Institute of Oncology, advocates for early palliative care integration in pediatric patients with hematologic diseases. Improving end-of-life care for pediatric ...
STOCKHOLM, June 12, 2025 /PRNewswire/ -- Sobi® (STO: SOBI) will present data at the 30th EHA (European Haematology Association) hybrid congress, in Milan, Italy (12-15 June). The congress will feature ...
- Nine abstracts across Takeda’s hematology portfolio and pipeline demonstrate Takeda’s commitment to patient-centric, innovative care that aims to drive greater treatment outcomes - Includes data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results